Max Bronstein | Senior Director, Health Policy And Corporate Affairs
Audentes Therapeutics

Max Bronstein, Senior Director, Health Policy And Corporate Affairs, Audentes Therapeutics

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 16:00

Advancing a national legislative framework for payment-over- for gene therapy products

last published: 24/Mar/19 01:45 GMT

back to speakers